You are here

CMI Medical | CENTER FOR CERTIFICATION OF MEDICAL DEVICES

CMI | Czech Metrology Institute

Czech Metrology Institute (CMI) is a state contributory organisation established by the Ministry of Industry and Trade in 1993. As the national metrology institute of the Czech Republic, it carries out activities in the field of metrology and also operates in other regulated areas, including conformity assessment of medical devices.

Conformity assessment of medical devices is carried out by the specialised organisational unit Centre for Certification of Medical Devices – CMI Medical.

The principles on which CMI bases the quality of its activities are summarised in the CMI quality policy statement.

CMI Medical | Notified Body NB 1383 for conformity assessment under the MDR

CMI Medical is a specialised internal organisational unit of Czech Metrology Institute for conformity assessment of medical devices. The notified body under the MDR is Czech Metrology Institute (NB 1383).

On 22 December 2023, CMI was designated as a notified body under Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (MDR). Within the scope of its designation, it carries out in particular:

  • conformity assessment of medical devices under the MDR, including the issuance of the relevant certificates following a positive assessment outcome
  • surveillance and other post-certification activities in accordance with MDR requirements

CMI's designation as a notified body is evidenced by the Confirmation of the Establishment of Authorisation issued by the Czech Office for Standards, Metrology and Testing (document available only in Czech).

Our vision

Our aim is to combine a high level of expertise with impartial, transparent and clearly conducted conformity assessment. We strive for a clearly defined and as predictable a process as possible, while rigorously maintaining the notified body's independence and objectivity. Responsibility for the medical device's conformity with the MDR remains with the manufacturer; CMI's role is to independently assess whether the applicable requirements are fulfilled.

Scope of notification

The scope of notification determines the devices and procedures for which CMI, as a notified body, may carry out conformity assessment. One of the first steps for a manufacturer is therefore to verify whether the intended assessment falls within CMI's current scope. What matters is not a single item of information, but a combination of the device characteristics, relevant MDR codes, risk class, selected conformity assessment procedure and any limitations or special procedures.

For practical orientation, it is useful to consider three interrelated areas:

1. MDR codes

MDR codes are used to define the notified body's scope of designation and the expertise required to assess a particular device. The individual groups of codes serve different purposes:

  • MDA / MDN: basic codes reflecting in particular the design and intended purpose of the device.
  • MDS: horizontal codes reflecting specific characteristics of the device, such as sterile condition, the use of software or nanomaterials.
  • MDT: horizontal codes describing manufacturing technologies and processes that are particularly relevant to the planning and conduct of audits.

When reviewing the information provided, CMI verifies whether the relevant combination of codes falls within its scope and whether it has the appropriate expert resources available for the requested assessment. An overview of CMI's current codes is available on the CMI scope for conformity assessment.

2. Risk class and conformity assessment procedure

The risk class of the device affects whether the involvement of a notified body is required and which conformity assessment procedures are applicable under the MDR. For class I devices, the notified body is involved only for devices placed on the market in sterile condition (Is), devices with a measuring function (Im) and reusable surgical instruments (Ir), and only with regard to the relevant aspects.

  • Conformity assessment procedure: the procedure selected under Article 52 and Annexes IX to XI of the MDR must be included in the scope for which CMI is designated.
  • Conditions and limitations: the scope may contain specific conditions or limitations. A match with a single MDR code alone therefore does not necessarily mean that every device falling under that code can be assessed by the notified body concerned.

If you are only beginning to prepare for assessment, the basic relationships between classification, documentation and the choice of procedure are summarised on the Preparing for the conformity assessment process at CMI.

3. Special procedures and additional requirements

For some devices, the MDR provides for additional specific procedures or consultations, for example for devices containing a medicinal substance, certain tissues or cells, or devices subject to the clinical evaluation consultation procedure (CECP).

  • Applicability of the procedure: depends on the specific characteristics of the device and the selected conformity assessment procedure.
  • CMI scope: CMI may carry out the requested assessment only if it falls within its valid scope of designation and the necessary expert and procedural resources are available.

Not sure whether your device falls within CMI's scope? As part of preparing a Non-Binding Quotation (NBQ) in response to a Non-Binding Inquiry submitted by the manufacturer, CMI will verify, based on the information provided, whether it can carry out the requested assessment. Regulatory and procedural questions may also be clarified, within the permissible scope, through structured dialogue. Responsibility for fulfilling MDR requirements and for choosing specific solutions remains with the manufacturer.

We are accepting new Non-Binding Inquiries under the MDR

CMI Medical is currently accepting new Non-Binding Inquiries for conformity assessment of medical devices under the MDR within the scope of CMI's designation. A Non-Binding Inquiry is the first step towards obtaining a Non-Binding Quotation (NBQ) for conformity assessment.

Based on the information provided in the inquiry, CMI will verify free of charge whether it can carry out the requested assessment and whether it has the necessary capacity available. If so, it will prepare a Non-Binding Quotation (NBQ) with a preliminary estimate of the price and time required. Once the quotation has been accepted, the applicant may submit an application for conformity assessment.

If you are just starting to prepare for certification under the MDR, see the Getting started with the MDR. More detailed information on preparing the documentation is available on the Preparing for the conformity assessment process at CMI. Regulatory and procedural questions may be clarified, within the permissible scope, through structured dialogue and information on rates and how the price is determined is available in the price list.

E-mail: medical [at] cmi [dot] gov [dot] cz (subject: Web%20Inquiry) (medical@cmi.gov.cz)

Phone: +420 770 399 663

CMI Medical | Why choose us

CMI Medical combines the stable institutional background of the national metrology institute and CMI's long-standing experience in regulated conformity assessment with the expertise of a team specialising in medical devices. Conformity assessment under the MDR involves qualified experts in technical assessment, pre-clinical evaluation, clinical evaluation and audits.

In addition to expertise and impartiality, we place emphasis on clear communication, available capacity, transparent pricing conditions and a process that is as predictable as possible.

ČMI Medical – Posuzování shody zdravotnických prostředků podle MDR, Notified Body 1383

30+ years of CMI tradition

The stable institutional background of the national metrology institute and CMI’s long-standing experience with conformity assessment in several regulated areas.

Leading experts

A qualified team for technical assessment, pre-clinical evaluation, clinical evaluation and audits.

Proven quality management system

The quality management system builds on CMI’s long-standing experience with regulated activities and conformity assessment.

Attractive pricing

Transparent pricing conditions and a preliminary cost estimate already provided in the Non-Binding Quotation (NBQ).

More information

Scope of notification

A broad portfolio of devices, technologies and procedures within CMI’s valid scope of designation.

More information

Reliable communication

Clear and responsive communication throughout the individual stages of conformity assessment.

Structured dialogue

Early clarification of permissible regulatory and procedural questions can improve process predictability and reduce unnecessary iterations.

More information

MEDECA

CMI Medical's own electronic system for clear and structured communication throughout conformity assessment.

You must have Javascript enabled to use this form.